Rapid weight loss can contribute to muscle loss, whereas a slower reduction in body fat may help preserve lean muscle mass
Originally developed to treat type 2 diabetes, GLP-1 medications have become wildly popular due to their ability to help people lose weight by slowing digestion and reducing appetite
BPC-157 has anti-inflammatory properties, while GHK-Cu helps protect cells from damage caused by free radicals
Current Research Limitations It is important to note that much of the research on BPC-157 comes from animal studies and laboratory models
Adjusting calorie intake, increasing physical activity, and ensuring adequate sleep can help break the plateau
Fig.3 Proportion of patients achieving MASH resolution without worsening of fibrosis with tirzepatide [6] While GLP-1 RAs are proving effective in treating MASH, their lack of direct action on liver tissue could limit their effectiveness in patients with advanced liver fibrosis or cirrhosis